Literature DB >> 10698485

NAT1*10 and NAT1*11 polymorphisms and breast cancer risk.

R C Millikan1.   

Abstract

Several recent epidemiological studies examined the association of N-acetyltransferase (NAT) 1 and 2 genotypes and breast cancer risk. Taken together, these studies do not support a strong role for the most common NAT alleles in etiology of breast cancer. Only one study estimated odds ratios (ORs) for the relatively rare NAT1*11 allele: a strong positive association for the NAT1*11 allele and breast cancer was reported, as well as strong combined effects for NAT1*11-containing genotypes and two environmental factors, smoking and red meat consumption. To further address the association of NAT1*11 and breast cancer, an analysis was performed using previously collected data from the Carolina Breast Cancer Study, a population-based, case-control study conducted in North Carolina. The OR for NAT1*11-containing genotypes and breast cancer was 0.5 (95% confidence interval, 0.2-1.3) among white women; ORs were not calculated among African Americans because only one participant exhibited the NAT1*11 allele. There was no evidence for combined effects of NAT1*11 and smoking. Unfortunately, the results of both studies of NAT1*11 are imprecise and lack sufficient statistical power to address fully the potential contribution of NAT1*11 to breast cancer. These results illustrate that the limitations imposed by sample size, as well as incomplete knowledge of biological function, need to be considered when planning and interpreting studies of genetic polymorphisms and environmental exposures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698485

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

1.  The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies.

Authors:  M Elizabeth Hodgson; Andrew F Olshan; Kari E North; Charles L Poole; Donglin Zeng; Chiu-Kit Tse; Tope O Keku; Joseph Galanko; Robert Sandler; Robert C Millikan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

2.  Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.

Authors:  David F Barker; Anwar Husain; Jason R Neale; Benjamin D Martini; Xiaoyan Zhang; Mark A Doll; J Christopher States; David W Hein
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

3.  Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach.

Authors:  Nadine Stephenson; Lars Beckmann; Jenny Chang-Claude
Journal:  Epidemiol Perspect Innov       Date:  2010-11-16

4.  NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Kunyi Zhang; Lijuan Gao; Yuqi Wu; Jianyi Chen; Chengguang Lin; Shaohua Liang; Jianxin Su; Jinming Ye; Xuyu He
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5α-androstane-3β,17β-Diol, or Dihydrotestosterone in Breast Cancer Cells.

Authors:  Xiaoyan Zhang; Samantha M Carlisle; Mark A Doll; Robert C G Martin; J Christopher States; Carolyn M Klinge; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

Review 6.  Review of studies on metabolic genes and cancer in populations of African descent.

Authors:  Camille C Ragin; Scott Langevin; Scott Rubin; Emanuela Taioli
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.